- Home
- ITRM vs PAVS Comparison
ITRM vs PAVS Comparison
Compare ITRM & PAVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- PAVS
- Stock Information
- Founded
- ITRM 2015
- PAVS 2004
- Country
- ITRM Ireland
- PAVS United States
- Employees
- ITRM N/A
- PAVS N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- PAVS Medicinal Chemicals and Botanical Products
- Sector
- ITRM Health Care
- PAVS Health Care
- Exchange
- ITRM Nasdaq
- PAVS Nasdaq
- Market Cap
- ITRM 40.0M
- PAVS 45.1M
- IPO Year
- ITRM 2018
- PAVS 2019
- Fundamental
- Price
- ITRM $0.48
- PAVS $0.89
- Analyst Decision
- ITRM Strong Buy
- PAVS
- Analyst Count
- ITRM 1
- PAVS 0
- Target Price
- ITRM $9.00
- PAVS N/A
- AVG Volume (30 Days)
- ITRM 1.2M
- PAVS 683.3K
- Earning Date
- ITRM 11-14-2025
- PAVS 08-04-2025
- Dividend Yield
- ITRM N/A
- PAVS N/A
- EPS Growth
- ITRM N/A
- PAVS N/A
- EPS
- ITRM N/A
- PAVS N/A
- Revenue
- ITRM $390,000.00
- PAVS $71,542.00
- Revenue This Year
- ITRM N/A
- PAVS N/A
- Revenue Next Year
- ITRM $482.25
- PAVS N/A
- P/E Ratio
- ITRM N/A
- PAVS N/A
- Revenue Growth
- ITRM N/A
- PAVS N/A
- 52 Week Low
- ITRM $0.36
- PAVS $0.43
- 52 Week High
- ITRM $3.02
- PAVS $1.50
- Technical
- Relative Strength Index (RSI)
- ITRM 41.91
- PAVS 69.83
- Support Level
- ITRM $0.36
- PAVS $0.56
- Resistance Level
- ITRM $0.49
- PAVS $0.74
- Average True Range (ATR)
- ITRM 0.05
- PAVS 0.11
- MACD
- ITRM -0.00
- PAVS 0.04
- Stochastic Oscillator
- ITRM 43.47
- PAVS 84.48
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.